Lactobacillus rhamnosus GG-derived EVs can modulate intestinal immunity and gut microbiota, and enhance the efficacy of anti-PD-1 immunotherapy for CRC in mice (Lu et al. 2023a, b). Here, PDCD1 is linked to colorectal carcinoma.